365 related articles for article (PubMed ID: 18082476)
41. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance.
Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
Liver Int; 2015 Mar; 35(3):944-52. PubMed ID: 24684289
[TBL] [Abstract][Full Text] [Related]
42. Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents.
Caranti DA; de Mello MT; Prado WL; Tock L; Siqueira KO; de Piano A; Lofrano MC; Cristofalo DM; Lederman H; Tufik S; Dâmaso AR
Metabolism; 2007 Sep; 56(9):1293-300. PubMed ID: 17697875
[TBL] [Abstract][Full Text] [Related]
43. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
[TBL] [Abstract][Full Text] [Related]
44. Association of total body and visceral fat mass with iron deficiency in preadolescents: the Healthy Growth Study.
Moschonis G; Chrousos GP; Lionis C; Mougios V; Manios Y;
Br J Nutr; 2012 Aug; 108(4):710-9. PubMed ID: 22088365
[TBL] [Abstract][Full Text] [Related]
45. Factors associated with hepatic steatosis in obese children and adolescents.
Ruiz-Extremera Á; Carazo Á; Salmerón Á; León J; Casado J; Goicoechea A; Fernandez JM; Garofano M; Ocete E; Martín AB; Pavón E; Salmerón J
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):196-201. PubMed ID: 21788762
[TBL] [Abstract][Full Text] [Related]
46. Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome.
Pickhardt PJ; Jee Y; O'Connor SD; del Rio AM
AJR Am J Roentgenol; 2012 May; 198(5):1100-7. PubMed ID: 22528899
[TBL] [Abstract][Full Text] [Related]
47. Increased visceral adipocyte lipolysis--a pathogenic role in nonalcoholic fatty liver disease?
Thörne A; Löfgren P; Hoffstedt J
J Clin Endocrinol Metab; 2010 Oct; 95(10):E209-13. PubMed ID: 20660030
[TBL] [Abstract][Full Text] [Related]
48. Visceral Fat Area Is an Independent Risk Factor for Overweight or Obese Nonalcoholic Fatty Liver Disease in Potential Living Liver Donors.
Lee S; Kim KW; Lee J; Park T; Koo K; Song GW; Lee SG
Transplant Proc; 2022 Apr; 54(3):702-705. PubMed ID: 35256204
[TBL] [Abstract][Full Text] [Related]
49. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound.
Fernandes MT; Ferraro AA; de Azevedo RA; Fagundes Neto U
Acta Paediatr; 2010 Aug; 99(8):1218-23. PubMed ID: 20298493
[TBL] [Abstract][Full Text] [Related]
50.
Chabanova E; Fonvig CE; Bøjsøe C; Holm JC; Thomsen HS
Acad Radiol; 2017 Aug; 24(8):982-987. PubMed ID: 28462823
[TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.
Perez M; Gonzáles L; Olarte R; Rodríguez NI; Tabares M; Salazar JP; Jaimes S; García RG; López-Jaramillo P
Prev Med; 2011 Feb; 52(2):174-7. PubMed ID: 21147154
[TBL] [Abstract][Full Text] [Related]
52. Association of peripheral total and differential leukocyte counts with obesity-related complications in young adults.
Yoshimura A; Ohnishi S; Orito C; Kawahara Y; Takasaki H; Takeda H; Sakamoto N; Hashino S
Obes Facts; 2015; 8(1):1-16. PubMed ID: 25765160
[TBL] [Abstract][Full Text] [Related]
53. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
Pacifico L; Arca M; Anania C; Cantisani V; Di Martino M; Chiesa C
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
[TBL] [Abstract][Full Text] [Related]
54. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
[TBL] [Abstract][Full Text] [Related]
55. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study.
Reinehr T; Toschke AM
Arch Pediatr Adolesc Med; 2009 Aug; 163(8):709-15. PubMed ID: 19652102
[TBL] [Abstract][Full Text] [Related]
56. Hepatic fat, not visceral fat, is associated with gallbladder polyps: a study of 2643 healthy subjects.
Lim SH; Kim D; Kang JH; Song JH; Yang SY; Yim JY; Chung SJ; Kim JS; Cho SH
J Gastroenterol Hepatol; 2015 Apr; 30(4):767-74. PubMed ID: 25376159
[TBL] [Abstract][Full Text] [Related]
57. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556
[TBL] [Abstract][Full Text] [Related]
58. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
59. Fatty liver and the metabolic syndrome among Shanghai adults.
Fan JG; Zhu J; Li XJ; Chen L; Lu YS; Li L; Dai F; Li F; Chen SY
J Gastroenterol Hepatol; 2005 Dec; 20(12):1825-32. PubMed ID: 16336439
[TBL] [Abstract][Full Text] [Related]
60. Association of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children.
Malki GJ; Goyal NP; Ugalde-Nicalo P; Chun LF; Zhang J; Ding Z; Wei Y; Knott C; Batakis D; Henderson W; Sirlin CB; Middleton MS; Schwimmer JB
Metab Syndr Relat Disord; 2023 May; 21(4):222-230. PubMed ID: 37083405
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
